The governments of high-income countries and private organizations provide billions of dollars to developing countries for health. This type of development assistance can have a critical role in ensuring that life-saving health interventions reach populations in need.
F or every 1000 children born in low-income countries in 2013, 78.8 died before the age of 5 years. 1 For every 100 000 childbirths in 2013, 385.8 women died due to complications. 2 These estimates are 11.9 times and 20.8 times higher than the comparable rates in the United States. The majority of these deaths were preventable, but the health systems in resourcescarce settings are, in many cases, unable to provide services that could prevent these adverse outcomes. 3, 4 High-income countries have provided financial resources to the health sectors of developing countries to improve these systems and support interventions that can prevent premature death and disability.
These contributions, known as development assistance for health (DAH), have increased over the last 25 years. The funding from recently established programs exceeds those previously implemented. 5, 6 International nongovernmental organizations (NGOs) have increased in number and prominence. 7 Since 2000, public-private partnerships have emerged as new approaches for addressing health challenges. 8, 9 DAH is just 1 source of health financing in developing countries and its contribution varies from country to country. In some middleincome countries, DAH represents a relatively small fraction of total expenditure on health. In these settings, private spending and government spending account for most health spending. However, in lowincome countries in sub-Saharan Africa, DAH accounted for 40.2% of total health expenditure in 2012. 10 The increase in DAH is important in these contexts, contributing to increased capacity for prevention and treatment for certain diseases and health conditions.
The objective of this study was to identify the amount of development assistance that countries and organizations provided for health and to determine the health areas that received these funds.
Methods

Conceptual Framework
Development assistance for health is the in-kind and financial resources transferred from primary development channels to developing countries for the purpose of maintaining or improving health. 11, 12 For this study, the developing countries were defined as countries that were low-and middle-income countries as determined by the World Bank. 13 Because countries can "graduate" from being classified as middle-income to being classed as high-income, the number of developing countries changes over time. From 1990 to 2012, between 146 and 183 countries were eligible to receive DAH based upon this classification. The countries and years in which they were eligible are listed in eTable 1 in the Supplement.
DAH was estimated by assessing the funding of the 38 primary channels (agencies and organizations) through which DAH was disbursed. These primary channels are listed in eTable 4 in the Supplement. All the members of the Organisation for Economic Cooperation and Development's (OECD's) Development Assistance Committee (DAC) were considered. The OECD DAC is the preeminent coordinating body for development assistance from highincome countries. 14 DAH was tracked from 24 of the 29 DAC members. The Czech Republic, Poland, Iceland, Slovak Republic, and Slovenia were not included because they joined the DAC recently and data on their disbursements are not available for the entire study period. These disbursements capture direct transfers from high-income countries to developing countries. They also include the activities of bilateral aid agencies, which are governmental organizations of high-income countries that provide DAH to recipient nations. The US Agency for International Development (USAID), for example, is the bilateral aid agency in the United States. In addition to the bilateral contributions of these countries, all multilateral agencies active in the health sector were included. In our analysis, multilateral agencies are international organizations that receive financial and political support from multiple high-income governments and other donors to improve health in low-and middle-income countries. These entities include the World Bank, World Health Organization (WHO), and the United Nations Children's Fund (UNICEF). Finally, because of their sizable contributions of DAH, this study also tracked DAH from the Global Fund to Fight AIDS, Tuberculosis, and Malaria (the Global Fund); Gavi, the Vaccine Alliance (Gavi); and the Bill and Melinda Gates Foundation (the Gates Foundation); private foundations in the United States; and NGOs receiving funding from the US government. Non-US foundations and NGOs that have not received support from the US government were not included because of data limitations. The set of primary channels tracked for this study was comparable or more expansive than previous research tracking DAH. 12, [15] [16] [17] DAH flows from source to channel to implementing institution. The source of funds is the government or private philanthropic entity that provided the resources, whereas the channel is the international agency or organization that directed the resources toward the implementing institution. Because collaboration among aid agencies occurs frequently, it is common for channels to transfer resources among themselves. For example, USAID provides resources for many NGOs, whereas the Global Fund provides resources to WHO and UNICEF. To avoid overestimating the resources available to developing countries, the funds transferred between channels were only counted once and resources were assigned to the final channel that directed the funds. The final channel, like the source of funds, has a unique and important discretionary role in determining where and how the resources are disbursed.
Data Sources
Detailed budget, revenue, and expenditure data for each channel were collected for 1990 through 2014. Resources were traced backward from the channel to determine the source of funds and forward to determine which countries and health focus areas were targeted. More than 60 data sources were utilized (eMethods in the Supplement). Data were collected from the OECD's Creditor Reporting System (CRS); the OECD's DAC; project-level data from the Gates Foundation, the Global Fund, Gavi, and the World Bank; grantlevel data from the Foundation Center; NGO data from USAID's annual Report of Voluntary Agencies; and a diverse set of audited financial records and annual budgets. [18] [19] [20] [21] [22] [23] [24] [25] Estimates begin in 1990 for 2 reasons. First, DAH was disbursed in a different context during the Cold War era that concluded in 1989. 26 Second, the OECD has recommended detailed analysis on the CRS data not be conducted prior to the 1990s because data before 1990 were incomplete. 27 Primary data distinguished the commitments of channels from their disbursements. Because disbursements reflect the actual amount of resources delivered, these were tracked. When projectlevel disbursement data were not available, commitment data and estimated disbursement schedules, which are based on projects for which disbursement and commitment data are both observed, were used to estimate disbursements. Disbursement schedules are channel-and project-length specific and reflect how each channel generally disburses resources over time.
Data-reporting lags prevented the use of the standard accounting methodology for the most recent years. When project-level data were not available, disbursements were estimated using commitment and budget data that extended through 2014. We used a weighted mean across time to estimate the percentage of DAH disbursed relative to budgeted amounts, and, when necessary, generated recent estimates based on these disbursement patterns and the available budget data. The monetary value of all transfers was converted into 2014 US dollars so that the estimates reflected real expenditure and were not influenced by inflation rates. 28
Development Assistance and Health Focus Areas
All available data were used to determine the health focus areas targeted by each channel. Resources were divided into 11 health focus areas based upon observed patterns in the data: human immunodeficiency virus (HIV)/AIDS, tuberculosis, malaria, newborn and child health, maternal health, other infectious diseases, noncommunicable diseases, and sector-wide approaches and health system strengthening (SWAps and HSS). These health focus areas are the major foci of the channels and the major areas of interest in global health and were selected prior to data collection. For example, the Global Fund has 3 principal foci-HIV/AIDS, tuberculosis, and malaria-whereas Gavi focuses on vaccines and WHO divided its programmatic expenses into 7 categories, all of which were captured. To assess if any major health focus areas were missed, the frequency of all words used in project descriptions across all projectlevel data was calculated. Informative terms with high frequency, such as "diarrhea" and "health system strengthening," suggested categories that were added or further subdivided. In addition to these, DAH targeting the prevention and treatment of Ebola was split from other infectious diseases for 2014 to account for the substantial amount of resources targeting the crisis in West Africa. 29 Two residual health focus areas were also generated. Funds designated as "other" did not fit into one of the primary health focus areas. DAH disbursements with insufficient information to identify the health focus area were designated as "unallocable." Thus, 11 health focus areas in all were evaluated.
Health focus areas are mutually exclusive, such that each dollar of DAH is assigned to only 1 health focus area. When a project was deemed to have 2 health foci, for example, HIV/AIDS and tuberculosis, the project's annual disbursements were divided proportionally across the appropriate health focus areas, using weights based on keyword searches in the project titles and descriptions. To generate health focus area estimates for years when reporting lags prevented the utilization of project-level data, a nonlinear, regressionbased smooth was used to extend logit-transformed health focus area, channel-specific shares until 2014. This method was applied because it performed best, relative to a large set of alternative methods, in out-of-sample validation predicting 2011 and 2012 channelspecific health area shares. Disability-adjusted life year (DALY) data from the Global Burden of Disease 2013 study were used to compare DAH with disease burden. 30, 31 DALYs are a summary measure of population health expressed as the number of years lost due to disability or premature death. The Institute for Health Metrics and Evaluation and a consortium of more than 1000 researchers in more than 100 countries produced DALY estimates for more than 300 diseases for 188 countries for the Global Burden of Disease 2013 study.
Development Assistance and Sources
Many channels, such as bilateral aid agencies and the Gates Foundation, received funds from a single source, such as national treasuries or the Bill and Melinda Gates Foundation Asset Trust, respectively. Other channels, such as the European Commission, UN agencies, the World Bank, Gavi, and the Global Fund, received funds from multiple sources. Revenue statements were used to trace the funds from these channels to the appropriate source. None of the channels tracked allow donors to provide funds for specific types of projects, so channel-level disbursements for each health focus area were proportionally allocated to each source.
Results
Growth Estimates
Between 1990 and 2014, $458.0 billion was disbursed from the major channels in high-income countries (n = 38) to developing countries (n = 146-183) to maintain or improve health. Annual disbursements increased substantially over time. In 1990, donors disbursed $6.9 billion for health. In 2014, they disbursed $35.9 billion. This increase can be divided into approximately 3 periods, as illustrated in Figure 1 . From 1990 to 2000, total DAH increased 5.4% annually. From 2000 through 2010, DAH accelerated and disbursements increased by 11.3% annually. Since 2010, funding has increased 1.4% annually. The UK government, which also preferred to fund its own public agencies, prioritized a broader array of health focus areas. Between 2012 and 2014, the UK government directed $5.2 billion or 48.5% of its resources to UK public agencies, but also channeled substantial shares of resources through Gavi, the UN agencies, and the Global Fund. Newborn and child health received more UK DAH than any other health focus areas ($3.2 billion or 29.9%), although HIV/ AIDS received $1.8 billion or 16.6% and maternal health received $1.0 billion or 9.4% of UK's DAH.
Global Estimates by Source and Channel
PanelCshowsthatprivatedonorstendedtosupportprivateNGOs, private foundations, and the UN agencies. These channels supported a wide variety of health projects, although like DAH from the UK, newborn and child health has been the largest recipient of private DAH over the last 3 years. The Gates Foundation disbursed $4.7 billion or 56.9% of its DAH through the foundation, but also transferred a substantial amount of DAH to UN agencies, NGOs, the Global Fund, and Gavi. The largest share of Gates Foundation funding was provided for newborn and child health, which received $3.3 billion or 40.2% of funds originating from the Gates Foundation over the 2012-2014 period.
Comparing DAH Health Focus Areas, 2012-2014 Figure 4 highlights the 2 largest health focus areas over the last 3 years, HIV/AIDSandnewbornandchildhealth,whichreceivedtheirresources fromdistinctlydifferentsourcesandchannels.Between2012and2014, theUSgovernmentprovided$20.1billionor62.7%ofallHIV/AIDSDAH, with $16.7 billion or 83.0% channeled through US agencies and $2.4 billion or 11.8% channeled through the Global Fund. Only $3.0 billion or 9.2% of DAH for HIV/AIDS originated with private sources. In contrast, DAH for newborn and child health came from a wide range of sources and channels. The United States, the United Kingdom, and private philanthropies each provided more than 10% of the DAH for newborn and child health over the last 3 years. The primary channels providing DAH for newborn and child health were the UN agencies, Gavi, the World Bank, NGOs, US bilateral agencies, and the Gates Foundation. 
Discussion
This research highlights the substantial increases in DAH disbursed between 1990 and 2014. In 1990, $6.9 billion was disbursed; in 2014, $35.9 billion was disbursed. Although all health focus areas increased over time, there has been a substantial focus on HIV/AIDS, maternal health, and newborn and child health. Funding for [34] [35] [36] During this period, DAH for newborn and child health has particularly benefited from Gavi's support for vaccinations and ongoing support from UN agencies. Furthermore, the UK government and the Gates Foundation have focused on maternal health, as evidenced by the 2012 London Summit on Family Planning and their growing contributions to this area of global health. 34 Increased funding for maternal health and newborn and child health since 2010 has been greater than growth in infectious disease areas in this same period. Figures 1 and Figure 5 highlight that noncommunicable diseases received very little development assistance relative to other health focus areas and relative to the large noncommunicable diseases health burden. 15,37-40 Despite currently lagging behind the DAH disbursed for other health focus areas, DAH targeting noncommunicable diseases increased in the most recent period. The annualized growth rate of the most recent 5 years of data showed that DAH for noncommunicable diseases increased at 5.2% per year, second only to that of newborn and child health. However, if countries are to be successful in reducing the health burdens of noncommunicable diseases, it is likely that greater support for system infrastructure and primary care will be necessary. 41, 42 Prevention, primary care, health system infrastructure, and cost-effective interventions have the potential to reduce the burden of noncommunicable diseases substantially in low-income countries. 37, 43 DAH for health sector support and sector-wide approaches was relatively small, compared with other health focus areas. This health focus area tracks resources allocated to governments for discretionary spending on health and often contributes to health system infrastructure and system-wide strengthening. These resources can theoretically result in the prevention and treatment of a wide variety of problems, and have the potential to improve health systems' ability to conduct surveillance and respond to crises. 44, 45 The Ebola epidemic in West Africa, for example, was a crisis exacerbated by weak health systems. 46 Although resources for health system strengthening and sector-wide approaches have increased since 1990, DAH for this health focus area amounted to only 6.1% of total DAH in 2014.
Global health financing flows are multifaceted, involving a wide range of institutions. The panels presented in Figures 2-4 capture that complexity, illustrating how different sources have preferred to allocate resources in distinct manners. Some governments, such as the US government, channeled a majority of funds through their own bilateral aid agencies. In contrast, private sources of global health financing disbursed a much higher share of funding through a wide range of private organizations, namely NGOs and foundations, in addition to UN agencies and other international organizations. These figures emphasize the distinct funding environments underpinning different areas of global health. Although the United States was the largest source and channel of HIV/AIDS financing, many other nations and organizations supported efforts to bolster funding for newborn and child health.
Comparing disability-adjusted life years with DAH provides an important perspective regarding the allocation of funding decisions. Maternal health and HIV/AIDS received the highest absolute DAH per DALY, despite different trends in growth and absolute disbursements. These health focus areas also contrasted in terms of trends in population need. The incidence of HIV/AIDS has begun to decline, but maternal mortality has not declined as quickly or substantially. 2, 47 This highlights the various considerations that are involved in decisions about DAH disbursements. Although some experts argue that cost-effective interventions should be prioritized, others emphasize that DAH should focus on the health focus areas with the greatest burden, and others still argue that donors should align their aid with the priorities of recipient governments. [48] [49] [50] [51] Nonetheless, bringing together disease burden and DAH by health focus area provides an approach for understanding the potential misallocation between resources and need. 15, 52 In addition to determining how to allocate DAH investments across health focus areas, donors also balance investment opportunities across time. DAH primarily represents resources allocated to programs intended to maintain and improve health in the present or near-term by investing in prevention and treatment for the current generation. DAH does not capture the vast majority of resources invested in research and development, which are intended to prevent and treat the ailments of future generations. Like DAH, crucial investments in research and development have been dominated historically by US public and private sources, and, in recent years, have been increasing at a notably slower pace. 53 In addition to the complex financing environment, this research also underlines the possible toll of the global financial crisis on DAH. 17 Disbursements of DAH slowed in 2010. If DAH had continued to increase after 2010 at the pace observed in the previous decade, it is possible that an additional $38.4 billion of development assistance would have been available for health in low-and middle-income countries over the 2010-2014 period, assuming that channels had maintained the same increase in contributions to DAH prior to the global financial crisis. The limitations of this research involve data availability and quality. Over time, the availability and timeliness of financial data provided by channels of development assistance have improved, as the International Aid Transparency Initiative and others have focused on improved reporting. 54 Although enhancing data quality is very good for policy makers and the global health community at large, the evolution of data quality may affect estimates of DAH trends. The primary concern about the estimates from the early years included in this study is that many resources were assigned to the "other" health focus area, as project descriptions were less comprehensive during this period. However, there is no evidence that these estimates are systematically distorted such that the trends being reported upon are caused by inadequate reporting. The amount of resources in the residual health focus areas ("other" and "unallocable") is not large enough to negate the estimated trends.
Despite collecting data from a diversity of sources, timely and detailed project-level data still need to be improved. In some cases, the estimates are affected by assumptions about how projects were divided across health focus areas, how commitments translated into disbursements, and how trends persisted in the most recent years. More exact resource accounting would be possible with improvements in the transparency of financial flows. Although improvements have been made in the availability and timeliness of data during the last several years, development agencies could strengthen their commitment to transparency by providing more detailed and timely records of their financial accounts and transfers.
Despite these limitations, the granular estimates provided by this research provide insight into the diverse funding environment underpinning global health. Many sources prioritized specific agencies and organizations. These intermediary channels prioritized specific health focus areas and recipient regions in a diverse manner as well. The flow of financial resources for health involves complex transfers among development assistance partners. Although some health focus areas received the majority of their support from a single channel or source, other health focus areas benefited from support from a broad donor base.
Conclusions
Funding for health in developing countries has increased substantially since 1990, with a focus on HIV/AIDS, maternal health, and newborn and child health. Funding from the US government has played a substantial role in this expansion. Funding for noncommunicable diseases has been limited. Understanding how funding patterns have changed across time and the priorities of sources of international funding across distinct channels, recipients, and health focus areas may help identify where funding gaps persist and where costeffective interventions could save lives.
